NO884741D0 - Amfotericin b/kolesterolsulfatpreparat og fremgangsmaate for fremstilling derav. - Google Patents

Amfotericin b/kolesterolsulfatpreparat og fremgangsmaate for fremstilling derav.

Info

Publication number
NO884741D0
NO884741D0 NO884741A NO884741A NO884741D0 NO 884741 D0 NO884741 D0 NO 884741D0 NO 884741 A NO884741 A NO 884741A NO 884741 A NO884741 A NO 884741A NO 884741 D0 NO884741 D0 NO 884741D0
Authority
NO
Norway
Prior art keywords
amphotericin
ampotericin
preparing
procedure
composition
Prior art date
Application number
NO884741A
Other languages
English (en)
Norwegian (no)
Other versions
NO884741L (no
Inventor
Robert Abra
Peter J Dehlinger
Original Assignee
Liposome Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Technology Inc filed Critical Liposome Technology Inc
Publication of NO884741L publication Critical patent/NO884741L/no
Publication of NO884741D0 publication Critical patent/NO884741D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nanotechnology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
NO884741A 1987-02-27 1988-10-25 Amfotericin b/kolesterolsulfatpreparat og fremgangsmaate for fremstilling derav. NO884741D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/019,575 US4822777A (en) 1987-02-27 1987-02-27 Amphotericin B/cholesterol sulfate composition
PCT/US1988/000599 WO1988006450A1 (fr) 1987-02-27 1988-02-26 Procede et composition de sulfate de cholesterol/amphotericine b

Publications (2)

Publication Number Publication Date
NO884741L NO884741L (no) 1988-10-25
NO884741D0 true NO884741D0 (no) 1988-10-25

Family

ID=21793937

Family Applications (1)

Application Number Title Priority Date Filing Date
NO884741A NO884741D0 (no) 1987-02-27 1988-10-25 Amfotericin b/kolesterolsulfatpreparat og fremgangsmaate for fremstilling derav.

Country Status (12)

Country Link
US (1) US4822777A (fr)
EP (1) EP0303683B1 (fr)
JP (1) JPH0610134B2 (fr)
AT (1) ATE88348T1 (fr)
AU (1) AU599779B2 (fr)
CA (1) CA1336890C (fr)
DE (1) DE3880397T2 (fr)
DK (1) DK174871B1 (fr)
FI (1) FI884889A0 (fr)
HK (1) HK80596A (fr)
NO (1) NO884741D0 (fr)
WO (1) WO1988006450A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0825869B2 (ja) * 1987-02-09 1996-03-13 株式会社ビタミン研究所 抗腫瘍剤包埋リポソ−ム製剤
US5032582A (en) * 1987-02-27 1991-07-16 Liposome Technology, Inc. Method for treating fungal infections with amphotericin B/cholesterol sulfate composition
US6406713B1 (en) 1987-03-05 2002-06-18 The Liposome Company, Inc. Methods of preparing low-toxicity drug-lipid complexes
US5616334A (en) * 1987-03-05 1997-04-01 The Liposome Company, Inc. Low toxicity drug-lipid systems
US5194266A (en) * 1989-08-08 1993-03-16 Liposome Technology, Inc. Amphotericin B/cholesterol sulfate composition and method
ATE176155T1 (de) * 1990-11-16 1999-02-15 Nippon Shinyaku Co Ltd Injizierbare amphotericin b enthaltende dispersion
AU664857B2 (en) * 1991-08-14 1995-12-07 Sequus Pharmaceuticals, Inc. HIV-treatment method with low-toxicity amphotericin B
US5264220A (en) * 1991-11-12 1993-11-23 Long David M Jr Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
AU5171293A (en) * 1992-10-14 1994-05-09 Regents Of The University Of Colorado, The Ion-pairing of drugs for improved efficacy and delivery
IT1283149B1 (it) * 1996-07-12 1998-04-07 Prodotti Antibiotici Spa Complessi di n'-dimetilaminoacetilpartricina a dimetilaminoetilamide, o suoi sali, e colesterol 3-solfato
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
KR100743404B1 (ko) 2000-12-21 2007-07-30 넥타르 테라퓨틱스 폴리엔 항균제의 폐 전달
TWI297335B (en) 2001-07-10 2008-06-01 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI252847B (en) * 2001-07-10 2006-04-11 Synta Pharmaceuticals Corp Synthesis of taxol enhancers
TWI332943B (en) * 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI330079B (en) * 2003-01-15 2010-09-11 Synta Pharmaceuticals Corp Treatment for cancers
TWI249408B (en) * 2003-12-10 2006-02-21 Ind Tech Res Inst New antifungal formulation and manufacturing method thereof
PL1781604T3 (pl) * 2004-06-23 2014-01-31 Synta Pharmaceuticals Corp Sole bis(tiohydrazydoamidu) do leczenia nowotworów
MX2007012688A (es) * 2005-04-15 2008-03-14 Synta Pharmaceuticals Corp Terapia de combinacion para el cancer con compuestos de bis(tiohidrazida) amida.
US7678832B2 (en) * 2005-08-16 2010-03-16 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amide) formulation
RU2475478C2 (ru) 2006-08-21 2013-02-20 Синта Фармасьютиклз Корп. Соединения для лечения пролиферативных расстройств
JP2010502616A (ja) * 2006-08-31 2010-01-28 シンタ ファーマシューティカルズ コーポレーション 癌を治療するためのビス（チオヒドラジドアミド）の組み合わせ
WO2008033494A2 (fr) * 2006-09-15 2008-03-20 Synta Pharmaceuticals Corp. Purification de bis(thiohydrazide amides)
US20100068251A1 (en) * 2006-10-10 2010-03-18 Jina Pharmaceuticals, Inc. Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
DE102015102210A1 (de) 2015-02-16 2016-08-18 Heraeus Medical Gmbh Antimykotischer polymerisierbarer Knochenzement und ein Verfahren zu seiner Herstellung
EP3585397A4 (fr) * 2017-02-21 2020-11-25 iCo Therapeutics Inc. Formulations orales solides d'amphotéricine b
CN110305926B (zh) * 2019-05-27 2021-02-26 浙江工业大学 一种基于两性霉素b代谢途径的发酵方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002741A (en) * 1974-04-24 1977-01-11 Valter Osvaldovich Kulbakh Meglumine complex fungicidal polyene macrolide antibiotic compositions and treatment method
US4468513A (en) * 1980-09-22 1984-08-28 Eli Lilly And Company 2'-N-Acylated and 2'-N-alkylated derivatives of 4-O-substituted-2-deoxystreptamine aminoglycosides
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation

Also Published As

Publication number Publication date
DE3880397D1 (de) 1993-05-27
ATE88348T1 (de) 1993-05-15
DE3880397T2 (de) 1993-07-29
DK598388A (da) 1988-10-27
JPH01502270A (ja) 1989-08-10
EP0303683B1 (fr) 1993-04-21
DK174871B1 (da) 2004-01-12
FI884889L (fi) 1988-10-21
FI884889A7 (fi) 1988-10-21
NO884741L (no) 1988-10-25
WO1988006450A1 (fr) 1988-09-07
FI884889A0 (fi) 1988-10-21
AU1482688A (en) 1988-09-26
DK598388D0 (da) 1988-10-27
HK80596A (en) 1996-05-17
EP0303683A1 (fr) 1989-02-22
JPH0610134B2 (ja) 1994-02-09
CA1336890C (fr) 1995-09-05
AU599779B2 (en) 1990-07-26
EP0303683A4 (fr) 1989-12-28
US4822777A (en) 1989-04-18

Similar Documents

Publication Publication Date Title
NO884741D0 (no) Amfotericin b/kolesterolsulfatpreparat og fremgangsmaate for fremstilling derav.
CS274681B2 (en) Method of erythropoietin's stabilized preparation production
AU555952B2 (en) Collagen implant containing active ingredient for implantation in bones
EP0156924A4 (fr) Composition chimiquement active contenant des ions ferreux.
EP0413953A3 (en) Copolymer as thickening agent in aqueous preparations active at a ph 5,5, process of its preparation and its use as thickening agent
CA2097199A1 (fr) Preparation de reactifs pour la determination du temps de prothrombine a partir d'un facteur tissulaire humain recombinant et de phospholipides synthetiques et naturels purifies
MX169329B (es) Composicion con bajo contenido de sal de sodio y metodo para su preparacion
IL109186A (en) Stable ingestable and absorbable nadh and nadph therapeutic compositions
AU7807791A (en) Method of treating impotence
SE8700137L (sv) Diuretisk komposition
CA2055695A1 (fr) Antigene immunoreactif s'apparentant au ca 195 tire du liquide amniotique humain
ZA837412B (en) Compressed products with retarded release of active substance
NZ229276A (en) Micronised 4-androstene-3,17-diones
AU2550688A (en) Toy
ZA91115B (en) Topical compositions
CA2068232A1 (fr) Composition supprimant la douleur et methode de preparation
AU1621788A (en) Pharmacologically active cholinergic compositions, and methods for making same and use thereof in treating disease
GB2258397A (en) Pharmaceutical compositions containing amethocaine
IE800344L (en) Anti-perspirant compositions
ZA897713B (en) Stabel aqueous solution of primycin,pharmaceutical and cosmetic compositions containing these solutions and process for preparing same
JPH049550U (fr)
ES8802560A1 (es) Un metodo para la preparacion de derivados estables efervescentes de acido acetilsalicilico con propiedades antihistaminicas.
ITRM910127U1 (it) Dentifricio biologico-polifunzionale, avente come principi attivi l'as ssociazione = cinque per cento: idrossilapatite, ca10(po4)6(oh)2 super
ES8505246A1 (es) Un procedimiento para estabilizar dextranaca en una composicion oral.
MY105595A (en) Stable aqueous solutions of primycin pharmaceutical and cosmetic compositions containing these solutions and process for preparing same